Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Glioblastoma × Diet Therapy × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 7 Breast Neoplasms 6 Obesity 4 Rectal Neoplasms 3 Colorectal Neoplasms 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Sarcoma 2 Radiation Injuries 2 Endometrial Neoplasms 2 Colonic Neoplasms 2 Weight Loss 1 Uterine Cervical Dysplasia 1 Stage IV Breast Cancer AJCC v6 and v7 1 Sezary Syndrome 1 Sexuality 1 Sexual Dysfunction, Physiological 1 Prostate Adenocarcinoma 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Overweight 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms, Plasma Cell 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1

Interventions

Temozolomide 186 Radiotherapy 109 Bevacizumab 84 Radiation 37 Irinotecan 26 Magnetic Resonance Spectroscopy 25 Carmustine 23 Surgical Procedures, Operative 21 Lomustine 19 Erlotinib Hydrochloride 18 Chemotherapy, Adjuvant 15 Carboplatin 15 sargramostim 11 Drug Therapy 11 temsirolimus 10 Radiosurgery 10 O(6)-benzylguanine 10 pembrolizumab 9 motexafin gadolinium 9 Vorinostat 9 Radiotherapy, Intensity-Modulated 9 Radiotherapy, Conformal 9 Imatinib Mesylate 9 Everolimus 9 Thalidomide 8 Sorafenib 8 Nivolumab 8 Gefitinib 8 cediranib 7 Sirolimus 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02286167 2020-05-12

GLAD

Wake Forest University Health Sciences

Phase NA Completed

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡